Archive: 03/19/2009

Naltrexone can help heavy social drinkers quit smoking

Naltrexone, an opioid antagonist approved in 1994 by the U.S. Food and Drug Administration for alcohol-dependence (AD) treatment, can reduce relapse rates among AD patients. Research on naltrexone's effectiveness on nicotine ...

dateMar 19, 2009 in Other
shares0 comments 0

Fetal alcohol syndrome testing expands

Improved technology, partnerships and collaboration across two provinces have allowed Queen's University scientists to dramatically expand the use of eye-movement tests that help identify and assess children ...

dateMar 19, 2009 in Neuroscience
shares0 comments 0